CTIS.eu › Cities › France › Nancy Cedex
Nancy Cedex
France
44 total trials
24 recruiting
2022-500862-93-00
5
2024-02-01
Pulmonary Hypertension
2022-501688-42-00
5
2023-05-24
Low Grade Glioma
2022-500520-30-00
5
2023-03-01
neurology
2022-502687-20-00
4
2022-09-14
Wilms tumor
2024-515136-72-00
6
2022-06-17
Patient with short bowel syndrome treated with antibiotics for a bacte
2023-506769-67-00
4
2024-09-04
Moderate to Severely Active Ulcerative Colitis
2023-506457-38-00
5
2024-06-05
Chronic kidney disease (CKD) and hypertension.
2022-500290-14-01
4
2023-05-11
Colitis ulcerative
2023-503444-13-00
5
2023-03-29
Relapsed/refractory multiple myeloma
2024-510800-35-00
5
2022-06-17
Relapsed or Refractory Multiple Myeloma (RRMM)
2023-506515-18-00
5
2020-10-23
Primary Progressive Multiple Sclerosis (PPMS)
2022-502478-18-00
4
2019-12-20
Acute Myeloid Leukemia (AML)
2023-504718-31-00
10
2019-10-19
Moderately to Severely Active Ulcerative Colitis
2024-516671-33-00
5
2021-05-24
Amyotrophic Lateral Sclerosis
2022-500536-11-01
5
2023-06-08
Moderately to severely active ulcerative colitis
2022-502078-17-00
4
2022-12-15
unresectable hepatocellular carcinoma
2023-503794-38-00
5
2022-11-24
Prevention of stroke or systemic embolism in atrial fibrillation
2023-509139-16-00
5
2022-05-13
Therapeutic confirmatory (phase III)
2024-511967-26-00
5
2016-11-21
AL Amyloidosis (Newly Diagnosed Systemic AL Amyloidosis)
2024-512804-20-00
5
Metastatic Colorectal Cancer
Showing 25–44 of 44 trials